Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose ...

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

A new class of non-opioid drugs treats pain by blocking signals before they reach the brain, reducing the risk of addiction.

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

The U.S. Food and Drug Administration has approved Vertex Pharmaceuticals' drug to treat acute pain, the health regulator ...

Christopher Groux is an editor, writer and accessibility advocate. Before joining the Forbes Health team, he covered Accessibility at Reviewed and gaming at Inverse and Newsweek. When he’s not ...

It may be, she added, that weekly therapy sessions are simply not scalable to a broad population, and the field should explore light-touch alternatives, like single-session interventions and ...

Get Instant Summarized Text (Gist) The delta opioid receptor (DOP) is identified as a promising target for developing rapid-acting antidepressants with minimal side effects. Selective DOP agonists ...

Jan 13 (Reuters) - The Sackler family owners of Purdue Pharma are offering to increase their financial contribution to a bankruptcy settlement of opioid lawsuits, while agreeing to some exposure ...

The Kroger Co. has agreed to pay Kentucky $110 million to settle a lawsuit filed last year alleging it pumped millions of doses of opioids into the state over the course of more than a decade.

COVINGTON, Ky. — Kroger will pay Kentucky $110 million in settlement funds that will ultimately go to combat the opioid crisis Kentucky Attorney General Russell Coleman says the business helped ...